NDC 83854-014-01 - ROPIVACAINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83854-014
- Requested NDC
- 83854-014-01
- Package NDCs from labels
- 83854-014-01, 83854-014-06, 83854-014-10, 83854-014-05, 83854-014-02, 83854-014-25, 83854-014-26
- Manufacturer
- Anthea Pharma Private Limited
- Effective date
- 2025-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ROPIVACAINE HYDROCHLORIDE - Anthea Pharma Private Limited | Anthea Pharma Private Limited | 2025-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83854-014-01 | ROPIVACAINE HYDROCHLORIDE | 30 mL in 1 VIAL | INJECTION, SOLUTION | 30 | 8 | |
| 83854-014-02 | ROPIVACAINE HYDROCHLORIDE | 20 mL in 1 VIAL | INJECTION, SOLUTION | 20 | 8 | |
| 83854-014-05 | ROPIVACAINE HYDROCHLORIDE | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 8 | |
| 83854-014-06 | ROPIVACAINE HYDROCHLORIDE | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 8 | |
| 83854-014-10 | ROPIVACAINE HYDROCHLORIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 8 | |
| 83854-014-25 | ROPIVACAINE HYDROCHLORIDE | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 8 | |
| 83854-014-26 | ROPIVACAINE HYDROCHLORIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 8 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sinus HP | ARSENICUM ALBUM, HEPAR SULPHURIS CALCAREUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA, THUJA OCCIDENTALIS | Energique, Inc. | 3cdddbe5-e3d2-4629-a045-868e18183f1d | 2023-12-19 | Warnings | 451W47IQ8X |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 | 2023-12-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Altachlore Sodium Chloride Hypertonicity | SODIUM CHLORIDE | Altaire Pharmaceuticals Inc. | dc0d94d8-4475-4956-8ded-bdb9496074e4 | 2023-12-09 | Warnings | 451W47IQ8X |
| terrasil Eczema and Psoriasis Severe Outbreak | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | 4d7128fb-57f1-4d0d-a83a-daef40928ecd | 2023-11-30 | Warnings | 451W47IQ8X |
| terragen HG Formula Maximum Strength | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | e632c831-e25d-4d04-ba72-2327d25713b1 | 2023-11-30 | Warnings | 451W47IQ8X |
| Femstat C | ECHINACEA (ANGUSTIFOLIA), FUCUS VESICULOSUS, HYDRASTIS CANADENSIS, PHYTOLACCA DECANDRA, KREOSOTUM, NATRUM MURIATICUM, CANDIDA ALBICANS, LYCOPODIUM CLAVATUM, PULSATILLA (PRATENSIS), SEPIA | Energique, Inc. | 420119ca-f2bf-40e3-9e40-00498724c228 | 2023-11-30 | Warnings | 451W47IQ8X |
| Endopar | GLANDULA SUPRARENALIS SUIS, HYPOPHYSIS SUIS, HYPOTHALAMUS SUIS, OOPHORINUM (SUIS), ORCHITINUM (BOVINE), PINEAL GLAND, THYROIDINUM, ARSENICUM ALBUM, BARYTA CARBONICA, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PULSATILLA (PRATENSIS) | Energique, Inc. | 06375c3e-cc05-4450-9117-1d3dc72636eb | 2023-11-21 | Warnings | 451W47IQ8X |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643994f-4e13-4572-e053-2991aa0a5b78 | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 6907bbfe-caa5-2ce4-e053-2991aa0ade8d | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643c518-13b2-658a-e053-2a91aa0ac5ed | 2023-11-14 | QTT17582CB | |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643e30e-1f47-09f1-e053-2991aa0ac2de | 2023-11-14 | QTT17582CB | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8646d7ea-cf5e-607d-e053-2a91aa0aeca1 | 2023-11-14 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86466121-7217-d053-e053-2a91aa0a8f8a | 2023-11-14 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 864669c9-5bdc-232f-e053-2a91aa0a1fc6 | 2023-11-14 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86462e06-d221-36b7-e053-2991aa0a1d82 | 2023-11-14 | 451W47IQ8X | |
| CV TOX | COCHLEARIA ARMORACIA, ECHINACEA (ANGUSTIFOLIA), LOMATIUM DISSECTUM, TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, PROPOLIS, GLANDULA SUPRARENALIS BOVINE, THYMUS (SUIS), ARANEA DIADEMA, IPECACUANHA, LYCOPODIUM CLAVATUM, MURIATICUM ACIDUM, NITRICUM ACIDUM, PHOSPHORICUM ACIDUM, RHUS TOX, SILICEA, EPSTEIN-BARR VIRUS NOSODE, HERPES ZOSTER NOSODE, MORBILLINUM, POLIOMYELITIS NOSODE, HEPATITIS B NOSODE, COXSACKIE B1 NOSODE, CYTOMEGALOVIRUS NOSODE, COXSACKIE B4 NOSODE, EPSTEIN BARR VIRUS NOSODE | BioActive Nutritional, Inc. | 8ef2fb5c-1b24-46a1-8d21-a78ce0a34a87 | 2023-11-07 | Warnings | QTT17582CB |
| Mineffect nasal mist | CALCAREA SILICATA, SILICEA, SULPHUR, NATRUM MURIATICUM, FERRUM METALLICUM, FERRUM PHOSPHORICUM, PHOSPHORUS, FERRUM MURIATICUM, TITANIUM METALLICUM, | Kadesh Incoporation Co,Ltd | 3a29bf95-a8a3-4517-aedf-0cd4a91b349c | 2023-10-31 | Warnings | 451W47IQ8X |
| Insomnia | AQUILEGIA VULGARIS, AVENA SATIVA, CHAMOMILLA, COFFEA CRUDA, CYPRIPEDIUM PUBESCENS, HUMULUS LUPULUS, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, MELATONIN, MELISSA OFFICINALIS, NATRUM MURIATICUM, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS | Liddell Laboratories, Inc. | 18c15f17-1a16-4595-9d23-20353363cd72 | 2023-10-31 | Warnings | 451W47IQ8X |
| Ahh Sleep | COFFEA CRUDA | Micro Balance Health Products | 08ea860f-0183-8ce8-e063-6394a90a582b | 2023-10-30 | Warnings | QTT17582CB |
| Saline | NASAL | GERI-CARE PHARMACEUTICAL CORP | d293cc13-4043-0d58-e053-2995a90a3fbc | 2023-10-24 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.